Project: Polypharmacology drug discovery platform to unlock novel chemical space for chemokine therapeutics
| Acronym | PROTEUS (Reference Number: 12132) |
| Duration | 01/04/2018 |
| Project Topic | InterAx Biotech and Stichting VU (Vrije Universiteit Amsterdam) will combine complementary technologies to design bioactive molecules that simultaneously target multiple chemokine receptors. A combination of systems biology, virtual screening and novel protein-based biosensors will allow for the design of new chemical modulators with well-defined polypharmacological effects that can serve as new therapeutics. This unique process will accelerate drug discovery for unmet needs in oncology. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 8 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | InterAx Biotech AG | Coordinator | Switzerland |
| 2 | Stichting VU (Vrije Universiteit Amsterdam) | Partner | Netherlands |